サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1401437

レッドバイオテクノロジーの世界市場規模調査＆予測、製品別、エンドユーザー別、地域別分析、2023-2030年

Global Red Biotechnology Market Size study & Forecast, by Product, by End-user and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
レッドバイオテクノロジーの世界市場規模調査＆予測、製品別、エンドユーザー別、地域別分析、2023-2030年
出版日: 2023年12月05日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レッドバイオテクノロジーの世界市場は、2022年に約5,155億8,000万米ドルと評価され、予測期間2023～2030年には10.6％以上の健全な成長率で成長すると予測されています。

メディカルバイオテクノロジーとしても知られるレッドバイオテクノロジーは、新しい医療・医薬品製品やアプリケーションを開発するために生物またはその産物を使用することに焦点を当てたバイオテクノロジーの一分野を指します。この分野は主にヘルスケア関連のアプリケーションを扱うことから「レッド」バイオテクノロジーと呼ばれ、赤色はしばしば医療・製薬業界を連想させます。市場成長を牽引する主な要因は、ヘルスケア支出の増加、高齢者人口の増加、慢性疾患の有病率の上昇、モノクローナル抗体、組み換えタンパク質、ワクチンなどのバイオ医薬品の開発・生産の拡大であり、これらは予測期間中の市場成長をサポートすると予想されます。

世界銀行によると、2020年には世界の高齢化率は10億人に達し、2030年には15億人に達すると予測されています。その結果、高齢者人口の増加が市場の成長を支えるものと予想されます。さらに、研究開発活動の活発化は、予測期間中に市場にとって有利な機会を創出すると予想されます。

しかし、高価な治療技術や機械は、2023-2030年の予測期間を通じて市場の成長を阻害します。

レッドバイオテクノロジーの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、主要な市場プレイヤーの存在、ヘルスケア支出の増加、研究開発活動の成長により、2022年の市場を独占しました。一方、アジア太平洋地域は、高齢者人口の増加、個別化医療に対する需要の高まり、地域の成長をサポートすると予想される臨床試験と研究の増加などの要因のため、予測期間中に最高のCAGRで成長すると予想されます。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 レッドバイオテクノロジー世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 レッドバイオテクノロジーの世界市場力学

  • レッドバイオテクノロジー市場の影響分析（2020～2030年）
    • 市場促進要因
      • 慢性疾患の増加
      • ゲノミクスと個別化医療の進歩
      • 高齢化とヘルスケア支出の増加
    • 市場の課題
      • 知的財産と特許の問題
    • 市場機会
      • 研究開発の成長

第4章 世界のレッドバイオテクノロジー市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 レッドバイオテクノロジーの世界市場：製品別

  • 市場スナップショット
  • レッドバイオテクノロジーの世界市場：製品別、実績 - ポテンシャル分析
  • レッドバイオテクノロジーの世界市場：製品別推定・予測、2020～2030年
  • レッドバイオテクノロジー市場、サブセグメント分析
    • モノクローナル抗体
    • ポリクローナル抗体
    • ワクチン
    • 細胞ベースの免疫療法製品
    • 遺伝子治療製品
    • 細胞治療製品
    • 組織工学製品
    • 幹細胞
    • 細胞培養
    • ウイルスベクター
    • 酵素
    • キットと試薬
    • 動物モデル
    • 分子診断薬
    • その他

第6章 レッドバイオテクノロジーの世界市場：エンドユーザー別

  • 市場スナップショット
  • レッドバイオテクノロジーの世界市場：エンドユーザー別、実績 - ポテンシャル分析
  • レッドバイオテクノロジーの世界市場：エンドユーザー別推定・予測、2020～2030年
  • レッドバイオテクノロジー市場、サブセグメント分析
    • 学術研究機関
    • CMOおよびCRO
    • 製薬・バイオテクノロジー企業
    • その他

第7章 レッドバイオテクノロジーの世界市場、地域分析

  • 主要国
  • 主な新興国
  • レッドバイオテクノロジー市場、地域別市場スナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • F. Hoffmann-La Roche AG
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Pfizer Inc
    • Regeneron Pharmaceuticals, Inc
    • Gilead Sciences Inc.
    • Biogen Inc.
    • Amgen Inc.
    • Celgene Corporation
    • Takeda Pharmaceutical Company Limited
    • AstraZeneca Plc
    • Merck KGaA

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Red Biotechnology Market, report scope
  • TABLE 2. Global Red Biotechnology Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Red Biotechnology Market estimates & forecasts by Product 2020-2030 (USD Billion)
  • TABLE 4. Global Red Biotechnology Market estimates & forecasts by end-user 2020-2030 (USD Billion)
  • TABLE 5. Global Red Biotechnology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 6. Global Red Biotechnology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Red Biotechnology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Red Biotechnology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Red Biotechnology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Red Biotechnology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Red Biotechnology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Red Biotechnology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Red Biotechnology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Red Biotechnology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. U.S. Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 17. U.S. Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. Canada Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. Canada Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. UK Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. UK Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. Germany Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. Germany Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. France Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. France Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. Italy Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. Italy Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Spain Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Spain Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. RoE Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. RoE Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. China Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. China Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. India Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. India Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. Japan Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. Japan Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. South Korea Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. South Korea Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. Australia Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. Australia Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. RoAPAC Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. Brazil Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. Brazil Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Mexico Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Mexico Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. RoLA Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. RoLA Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. Saudi Arabia Red Biotechnology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. South Africa Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoMEA Red Biotechnology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Red Biotechnology Market
  • TABLE 70. List of primary sources, used in the study of global Red Biotechnology Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Red Biotechnology Market, research methodology
  • FIG 2. Global Red Biotechnology Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Red Biotechnology Market, key trends 2022
  • FIG 5. Global Red Biotechnology Market, growth prospects 2023-2030
  • FIG 6. Global Red Biotechnology Market, porters 5 force model
  • FIG 7. Global Red Biotechnology Market, pest analysis
  • FIG 8. Global Red Biotechnology Market, value chain analysis
  • FIG 9. Global Red Biotechnology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Red Biotechnology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Red Biotechnology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Red Biotechnology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Red Biotechnology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Red Biotechnology Market, regional snapshot 2020 & 2030
  • FIG 15. North America Red Biotechnology Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Red Biotechnology Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Red Biotechnology Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Red Biotechnology Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Red Biotechnology Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Red Biotechnology Market is valued at approximately USD 515.58 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 10.6% over the forecast period 2023-2030., Red biotechnology, also known as medical biotechnology, refers to the branch of biotechnology that focuses on using living organisms or their products to develop new medical and pharmaceutical products and applications. This field is called "red" biotechnology because it primarily deals with healthcare-related applications, and the color red is often associated with the medical and pharmaceutical industries. The key factors driving the market growth is Increasing Healthcare Expenditure, growing old age population, Rising Prevalence of Chronic Diseases, and growing development and production of biopharmaceuticals, including monoclonal antibodies, recombinant proteins, and vaccines that anticipated to support the market growth during projected period.

According to The World Bank, in 2020, it was expected that aging people around the world accounted for 1 billion, which is projected to reach 1.5 billion by the year 2030 which represents that 1 in 6 people are more than 60 years of age. As a result, the growing old age population is anticipated to support the market growth. Additionally, growing research and development activities is anticipated to create the lucrative opportunity for the market during forecast period.

However, the costly therapeutic technology and machinery stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Red Biotechnology Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, rising healthcare expenditure, and growing research and development activities. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the growing old age population, rising demand for the personalized medicine, and growing Clinical Trials and Research that anticipated to support the region growth.

Major market player included in this report are:

  • F. Hoffmann-La Roche AG
  • Pfizer Inc
  • Regeneron Pharmaceuticals, Inc
  • Gilead Sciences Inc.
  • Biogen Inc.
  • Amgen Inc.
  • Celgene Corporation
  • Takeda Pharmaceutical Company Limited
  • AstraZeneca Plc
  • Merck KGaA

Recent Developments in the Market:

  • In August 2022, The U.S. FDA approved MYFEMBREE, a once-daily medication produced by Myovant Sciences and Pfizer with a 24-month maximum treatment period, for the management of moderate to severe endometriosis-related pain. For the management of mild to severe endometriosis-related pain, MYFEMBREE offers an effective once-daily therapeutic alternative.

Global Red Biotechnology Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Product, End-User, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Cell-Based Immunotherapy Products
  • Gene Therapy Products
  • Cell Therapy Products
  • Tissue-Engineered Products
  • Stem Cells
  • Cell Culture
  • Viral Vector
  • Enzymes
  • Kits and Reagents
  • Animal models
  • Molecular diagnostics
  • Others

By End-User:

  • Academic Research Institutes
  • CMOs & CROs
  • Pharmaceutical & Biotechnology Companies
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Red Biotechnology Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Red Biotechnology Market, by Product, 2020-2030 (USD Billion)
    • 1.2.3. Red Biotechnology Market, by End-user, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Red Biotechnology Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Red Biotechnology Market Dynamics

  • 3.1. Red Biotechnology Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of chronic diseases
      • 3.1.1.2. Advances in genomics and personalized medicine
      • 3.1.1.3. Aging population and increased healthcare expenditure
    • 3.1.2. Market Challenges
      • 3.1.2.1. Intellectual Property and Patent Issues
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing Research and Development

Chapter 4. Global Red Biotechnology Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Red Biotechnology Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Red Biotechnology Market by Product , Performance - Potential Analysis
  • 5.3. Global Red Biotechnology Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4. Red Biotechnology Market, Sub Segment Analysis
    • 5.4.1. Monoclonal Antibodies
    • 5.4.2. Polyclonal Antibodies
    • 5.4.3. Vaccines
    • 5.4.4. Cell-Based Immunotherapy Products
    • 5.4.5. Gene Therapy Products
    • 5.4.6. Cell Therapy Products
    • 5.4.7. Tissue-Engineered Products
    • 5.4.8. Stem Cells
    • 5.4.9. Cell Culture
    • 5.4.10. Viral Vector
    • 5.4.11. Enzymes
    • 5.4.12. Kits and Reagents
    • 5.4.13. Animal models
    • 5.4.14. Molecular diagnostics
    • 5.4.15. Others

Chapter 6. Global Red Biotechnology Market, by end-user

  • 6.1. Market Snapshot
  • 6.2. Global Red Biotechnology Market by end-use, Performance - Potential Analysis
  • 6.3. Global Red Biotechnology Market Estimates & Forecasts by end-user 2020-2030 (USD Billion)
  • 6.4. Red Biotechnology Market, Sub Segment Analysis

6.4.1. Academic Research Institutes

6.4.2. CMOs & CROs

6.4.3. Pharmaceutical & Biotechnology Companies

6.4.4. Others

Chapter 7. Global Red Biotechnology Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Red Biotechnology Market, Regional Market Snapshot
  • 7.4. North America Red Biotechnology Market
    • 7.4.1. U.S. Red Biotechnology Market
      • 7.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. end-user breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Red Biotechnology Market
  • 7.5. Europe Red Biotechnology Market Snapshot
    • 7.5.1. U.K. Red Biotechnology Market
    • 7.5.2. Germany Red Biotechnology Market
    • 7.5.3. France Red Biotechnology Market
    • 7.5.4. Spain Red Biotechnology Market
    • 7.5.5. Italy Red Biotechnology Market
    • 7.5.6. Rest of Europe Red Biotechnology Market
  • 7.6. Asia-Pacific Red Biotechnology Market Snapshot
    • 7.6.1. China Red Biotechnology Market
    • 7.6.2. India Red Biotechnology Market
    • 7.6.3. Japan Red Biotechnology Market
    • 7.6.4. Australia Red Biotechnology Market
    • 7.6.5. South Korea Red Biotechnology Market
    • 7.6.6. Rest of Asia Pacific Red Biotechnology Market
  • 7.7. Latin America Red Biotechnology Market Snapshot
    • 7.7.1. Brazil Red Biotechnology Market
    • 7.7.2. Mexico Red Biotechnology Market
  • 7.8. Middle East & Africa Red Biotechnology Market
    • 7.8.1. Saudi Arabia Red Biotechnology Market
    • 7.8.2. South Africa Red Biotechnology Market
    • 7.8.3. Rest of Middle East & Africa Red Biotechnology Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. F. Hoffmann-La Roche AG
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Pfizer Inc
    • 8.3.3. Regeneron Pharmaceuticals, Inc
    • 8.3.4. Gilead Sciences Inc.
    • 8.3.5. Biogen Inc.
    • 8.3.6. Amgen Inc.
    • 8.3.7. Celgene Corporation
    • 8.3.8. Takeda Pharmaceutical Company Limited
    • 8.3.9. AstraZeneca Plc
    • 8.3.10. Merck KGaA

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption